Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-11

Clinical Trial Update: Low Cost Biological Lung Volume Reduction Therapy for Advanced Emphysema [Phase 2]

View source ↗

Summary

Phase 2 trial of a low-cost biological lung volume reduction therapy for advanced pulmonary emphysema has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Low Cost Biological Lung Volume Reduction Therapy

Snippet

Sponsor: Mansoura University | Conditions: Pulmonary Emphysema | Phase 2 | Status: COMPLETED